Liberum Biotech
Toronto
About Liberum Biotech
Liberum offers next generation protein manufacturing. Taking advantage of our suite of proprietary molecular and hardware technologies, we bring speed, scalability and cost reduction to disrupt current biologics manufacturing practices. Our vision is to democratize access to the fruits of synthetic biology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.8M
- Funding stage: Seed
- Last round: Seed (Jul 2023)
- Website: liberumbio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/liberum-biotech-118151 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.